RECRUITING

Precision Optical Guidance for Oral Biopsy

Description

To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.

Conditions

Oral Lesions
Talk to us

Related Conditions:

Oral Lesions

Study Overview

On this page

Study Details

Study overview

To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.

Precision Optical Guidance for Oral Biopsy Based on Next-Generation Hallmarks of Cancer (1R01DE029590-01): A Clinical Study to Evaluate and Optimize the Technical Performance Characteristics of an Active Biopsy Guidance System

Precision Optical Guidance for Oral Biopsy

Condition
Oral Lesions
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adult subjects with clinically evident oral lesions such as leukoplakia or erythroplakia, oral potentially malignant disorders (OPMD) such as lichen planus and graft vs. host disease, pathologic diagnosis of dysplasia, squamous cell carcinoma, or a history of resected oral cancer, are eligible to participate. Patients with previous treatment including surgery, radiation, chemotherapy or other therapies are also eligible.
  • 2. Ability to understand and willingness to sign a written Informed Consent Document (ICD).
  • 1. Known allergy to proflavine or acriflavine.
  • 2. Age less than 18 years.
  • 3. Pregnant or nursing females.
  • 4. Adults unable to consent
  • 5. Prisoners and other vulnerable populations

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Ann Gillenwater, MD, PRINCIPAL_INVESTIGATOR, MD Anderson Caner Center

Study Record Dates

2025-03-31